Nuevo Almonertinib mesylate Ver en grande

Almonertinib mesylate

AM-M43838-25mg

Producto nuevo

Almonertinib mesylate is an orally active, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR sensitization and T790M resistance mutations, and also shows strong inhibitory activity against T790M, T790M/L858R, and T790M/Del19, with IC50 of 0.37, 0.29, and 0.21 nM, respectively. The IC50 of T790M/Del19 was 0.37, 0.29 and 0.21 nM, respectively, but the inhibitory effect on wild-type was weaker, with an IC50 of 3.39 nM. It can be used in the research of non-small cell lung cancer.

Al comprar este producto puede obtener hasta 78 puntos de fidelidad. Su cesta totalizará 78 puntos de fidelidad que se puede(n) transformar en un cupón de descuento de 15.60EUR.


Para ver ofertas debe ser usuario registrado. Registrarse.

Ficha de datos

Size25mg
Storage Conditions4°C, dry, sealed
Molecular WeightC31H39N7O5S
Research AreaEGFR/HER2
CAS Number'2134096-06-1